Furiex Pharmaceuticals, Inc. (FURX) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 154 transactions totaling $1.1B, demonstrating a bullish sentiment with $1.1B in net insider flow. The most recent transaction on Jul 2, 2014 involved a transaction of 9,308 shares valued at $0.
No significant insider buying has been recorded for FURX in the recent period.
No significant insider selling has been recorded for FURX in the recent period.
Based on recent SEC filings, insider sentiment for FURX is bullish with an Insider Alignment Score of 97/100 and a net flow of $1.1B. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Furiex Pharmaceuticals, Inc. (FURX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading FURX stock, having executed 154 transactions in the past 90 days. The most active insider is Laboratories, Llc Forest (Executive), who has made 1 transactions totaling $1.1B.
Get notified when executives and directors at FURX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 2, 2014 | Davis Stephen | Executive | Disposition | 9,308 | $N/A | $0 | |
| Jul 2, 2014 | W. Kaldor Stephen | Executive | Disposition | 7,160 | $N/A | $0 | |
| Jul 2, 2014 | Sherie Almenoff June | Executive | Disposition | 24,600 | $N/A | $0 | |
| Jul 2, 2014 | B. Corr Peter | Executive | Disposition | 8,447 | $N/A | $0 | |
| Jul 2, 2014 | Patel Sailash | Executive | Disposition | 26,444 | $N/A | $0 | |
| Jul 2, 2014 | L. Dixon Wendy | Executive | Disposition | 7,160 | $N/A | $0 | |
| Jul 2, 2014 | S. Covington Paul | Executive | Disposition | 22,523 | $N/A | $0 | |
| Jul 2, 2014 | Frances Mcintyre Gail | Executive | Disposition | 24,318 | $N/A | $0 | |
| Jul 2, 2014 | N. Eshelman Fredric | Executive | Disposition | 132,689 | $N/A | $0 | |
| Jul 2, 2014 | N. Eshelman Fredric | Executive | Disposition | 2,673,522 | $N/A | $0 | |
| Jul 2, 2014 | N. Eshelman Fredric | Executive | Disposition | 140 | $N/A | $0 | |
| Jul 2, 2014 | N. Eshelman Fredric | Executive | Disposition | 41,666 | $N/A | $0 | |
| Jul 2, 2014 | Llc Forest Laboratories, | Executive | Purchase | 11,169,066 | $95.00 | $1.1B | Large |
| Jun 24, 2014 | S. Covington Paul | Executive | Option Exercise | 10,368 | $17.80 | $184.6K | |
| Jun 24, 2014 | S. Covington Paul | Executive | Sale | 10,368 | $104.12 | $1.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 53 | $1.1B | 96.2% |
Sale(S) | 29 | $37.3M | 3.3% |
Exercise(M) | 37 | $5.9M | 0.5% |
Payment(F) | 3 | $419.5K | 0.0% |
Disposition(D) | 12 | $0 | 0.0% |
Award(A) | 17 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at Furiex Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 14 insiders making 154 transactions totaling $1.1B in purchases versus $37.3M in sales, the net buying activity of $1.1B signals strong executive confidence. Laboratories, Llc Forest (Executive) leads the buying activity with $1.1B in transactions across all time.